Michael Gelband’s Cineverse CNVS Stock Holding History

Michael Gelband’s Portfolio CNVS Stock Details CNVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,423	Closed	-$33K	–	2254
2021 Q4	$33K	Buy	+1,423	New	+$54.2K	﹤0.01%	2058

Other funds holding CNVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KPW

Kore Private Wealth New York $554M AUM 17.38% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Michael Gelband's CNVS Position: Q1 2022 in Review

Michael Gelband sold out of Cineverse (CNVS) in Q1 2022, closing a stake of 1,423 shares — an estimated $33K sold.

Michael Gelband first reported a position in CNVS in Q4 2021 and held it in 1 quarter. The position peaked at $33K in Q4 2021. 49 funds tracked by Wall St. Rank hold CNVS as of Q1 2022.

Michael Gelband reported no remaining Cineverse position as of Q1 2022 after selling out during the quarter.
Michael Gelband sold 1,423 Cineverse shares in Q1 2022, an estimated $33K.
Michael Gelband first reported a position in Cineverse in Q4 2021 and held it in 1 quarter.
Michael Gelband's Cineverse position peaked at $33K in Q4 2021.
49 funds tracked by Wall St. Rank held Cineverse as of Q1 2022.

Based on ExodusPoint Capital Management's 13F filing for Q1 2022, filed 13 May 2022.